AIDS Pricing Agreement Expected to Broaden Access to Hologic Infectious Disease Tests Public sector programs in some low- and middle-income countries will obtain access to Hologic's Panther system through a single, all-inclusive pricing structure. Sooty Mangabey Genome Insights May Inform AIDS Research An Emory University team has sequenced the genome of the sooty mangabey, comparing the DNA to other primates including humans to further research in AIDS resistance Florida STI Clinic to Use Cepheid CT/NG Assay in Rapid Diagnosis of Asymptomatic Patients Premium The clinic, a partnership of the Florida Department of Health in Broward County and the AIDS Healthcare Foundation hopes to improve STD treatment and control. NIH to Fund Genomic Research Into HIV/AIDS Drug Response The agency is seeking grant applications for projects using genomics to study HIV/AIDS drug responses and comorbidities. Brown Group Develops One-Step Ligation on RNA Amplification to Detect Drug-Resistant HIV Premium The method simplifies previous techniques, and preliminary testing using a microfluidic device indicates it could ultimately be used in low-resource settings. Feb 10, 2015 Rheonix Gets $1.5M NIH Grant to Commercialize POC HIV/AIDS Test Dec 29, 2014 Cepheid's HIV MDx Assay Gains CE-IVD Mark Nov 20, 2014 Studies Detail Improved Droplet Digital PCR Sensitivity for HIV Detection Premium Sep 26, 2014 Roche Partners on Launch of Global Program for HIV Testing Jul 18, 2014 UH Case Medical Center, Arup Labs Reach Marketing Deal on Sequencing-based HIV Test Apr 28, 2014 Diaxonhit Awarded $2.4M to Develop HIV CDx Jul 11, 2013 UW Wins $15M in NIAID Funds for Non-Human Primate Genomics Core Jul 10, 2013 Study Reveals Nature of Gut Microbiome Shifts During HIV Progression Dec 6, 2012 PEPFAR Invests Additional $11M to Supply Cepheid TB Test in 14 High-burden Countries Dec 5, 2012 Roche Diagnostics, PEPFAR Tackle HIV/AIDS in Africa Oct 11, 2012 Monkey Study Points to Gut Virome Shift During AIDS Development Jul 12, 2012 NIH To Fund Projects to ID miRNA Cancer Markers, Study Role of ncRNAs in HIV-Associated Disorders Premium May 23, 2012 NIAID to Fund Nonhuman Primate Genomics Lab for AIDS Studies Sep 23, 2011 Virginia Tech's SinkSource Algorithm Uses Interactome Data to Predict Protein Function Premium Aug 19, 2011 NextGen Inks Deal with University of Nebraska to Use Biomarker Discovery Panel for NeuroAIDS Work Premium Dec 24, 2010 Scientists Identify Protein Biomarkers for Guiding Antiretroviral Therapy in AIDS Patients Premium Nov 11, 2009 Pfizer/GSK HIV Spin-Off ViiV Healthcare Debuts With Personalized Drugs in Portfolio Premium Mar 10, 2009 Funding Update for Mar 10, 2009 Premium Mar 2, 2009 Mass. Union Wants Life Sciences Act Suspended Pending Provision Barring Non-Union Hiring Premium Feb 25, 2009 Monogram to Expand Oncology Franchise in '09 as '08 Revenues Rise 44 Percent Premium Load More Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.